Disruption of Bone Marrow Stem Cell Differentiation Profile During Development of Alzheimer’s Disease in Experimental 5xFAD Mice Leading to Production of IgGs Hydrolyzing Five Histones

Objective: It has been previously demonstrated that the development of numerous autoimmune and neurological diseases in humans, as well as in experimental autoimmune encephalomyelitis mice, results from a disruption in the differentiation profile of bone marrow stem cells (BMSCs). This disruption leads to inflammation and the emergence of antibodies with diverse catalytic activities. We hypothesized that the development of Alzheimer’s disease (AD), particularly at its early stages, may also be associated with an altered differentiation profile of BMSCs. Methods: One of the earliest and statistically reliable indicators of developing autoimmune reactions is the appearance of abzymes—catalytically active antibodies—in the blood of patients and mice, whereas they are absent in healthy donors. Immunoglobulin G (IgG) antibodies targeting five individual histones (H1, H2A, H2B, H3, and H4) were isolated from the blood of 5xFAD mice at various stages of AD progression. Results: It has been demonstrated that the development of AD in 5xFAD mice begins with an impairment of the BMSC differentiation profile. The isolated antibodies effectively hydrolyzed all five histones. The progression of AD over 10, 20, 40, and 100 days was associated with the development of autoimmune reactions, reflected by a steady increase in the number of cleavage sites across the five histones. Depending on the histone, this number rose from 1 to 9 cleavage sites at early time points to 16–18 sites by day 100, corresponding to advanced pathology. Conclusions: Potential reasons for the marked differences in the specific types and numbers of histone cleavage sites during the progression of Alzheimer’s disease are discussed.

Authors

Institutions

Publication Details

Journal
Current Issues in Molecular Biology
Published
2026-11-16
DOI
https://doi.org/10.3390/cimb48111233
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Disruption of Bone Marrow Stem Cell Differentiation Profile During Development of Alzheimer’s Disease in Experimental 5xFAD Mice Leading to Production of IgGs Hydrolyzing Five Histones

Kseniya S. Aulova, Pavel S. Dmitrenok, Чичерина Галина Сергеевна, Anna M. Timofeeva et al.
1 links
Current Issues in Molecular Biology
Alzheimer's disease research and treatments
article

Disruption of Bone Marrow Stem Cell Differentiation Profile During Development of Alzheimer’s Disease in Experimental 5xFAD Mice Leading to Production of IgGs Hydrolyzing Five Histones

Kseniya S. Aulova, Pavel S. Dmitrenok, Чичерина Галина Сергеевна, Anna M. Timofeeva, Georgy A. Nevinsky, Andrey E. Urusov, Alexander D. Chernyak, Ludmila B. Toporkova, Irina A. Orlovskaya
article en

Abstract

Objective: It has been previously demonstrated that the development of numerous autoimmune and neurological diseases in humans, as well as in experimental autoimmune encephalomyelitis mice, results from a disruption in the differentiation profile of bone marrow stem cells (BMSCs). This disruption leads to inflammation and the emergence of antibodies with diverse catalytic activities. We hypothesized that the development of Alzheimer’s disease (AD), particularly at its early stages, may also be associated with an altered differentiation profile of BMSCs. Methods: One of the earliest and statistically reliable indicators of developing autoimmune reactions is the appearance of abzymes—catalytically active antibodies—in the blood of patients and mice, whereas they are absent in healthy donors. Immunoglobulin G (IgG) antibodies targeting five individual histones (H1, H2A, H2B, H3, and H4) were isolated from the blood of 5xFAD mice at various stages of AD progression. Results: It has been demonstrated that the development of AD in 5xFAD mice begins with an impairment of the BMSC differentiation profile. The isolated antibodies effectively hydrolyzed all five histones. The progression of AD over 10, 20, 40, and 100 days was associated with the development of autoimmune reactions, reflected by a steady increase in the number of cleavage sites across the five histones. Depending on the histone, this number rose from 1 to 9 cleavage sites at early time points to 16–18 sites by day 100, corresponding to advanced pathology. Conclusions: Potential reasons for the marked differences in the specific types and numbers of histone cleavage sites during the progression of Alzheimer’s disease are discussed.

Current Issues in Molecular BiologyVol. 48(11)
Russian Academy of Sciences (RU), Institute of Systematics and Ecology of Animals (RU), Institute of Chemical Biology and Fundamental Medicine (RU), Pacific Institute of Bioorganic Chemistry. GB Elyakova Far Eastern Branch of the Russian Academy of Sciences (RU), Siberian Branch of the Russian Academy of Sciences (RU)
Good health and well-being
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon